 | • レポートコード：QAF27699 • 出版社/出版日：QYResearch / 2021年4月8日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の一般医薬品市場について種類別（シンプル一般医薬品、スーパー一般医薬品、バイオシミラー）、用途別（CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・一般医薬品市場の概要 ・世界の主要地域別一般医薬品市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の一般医薬品市場規模2016-2021：種類別（シンプル一般医薬品、スーパー一般医薬品、バイオシミラー） ・世界の一般医薬品市場予測2012-2027：種類別（シンプル一般医薬品、スーパー一般医薬品、バイオシミラー） ・世界の一般医薬品市場規模2016-2021：用途別（CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他） ・世界の一般医薬品市場予測2012-2027：用途別（CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他） ・一般医薬品のアメリカ市場規模と予測2016-2021 ・一般医薬品のヨーロッパ市場規模と予測2016-2021 ・一般医薬品の中国市場規模と予測2016-2021 ・一般医薬品の日本市場規模と予測2016-2021 ・一般医薬品の東南アジア市場規模と予測2016-2021 ・一般医薬品のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Teva、Novartis - Sandoz、Mylan、Sun Pharmaceutical、Aspen、Fresenius Kabi、Pfizer (Hospira)、Sanofi、Aurobindo、Lupin、Dr. Reddy's、Apotex、Cipla、ENDO (Par Pharmaceutical)、Stada Arzneimittel、Krka Group、Nichi-Iko Pharmaceutical、Valeant、Zydus Cadila、Hikma） ・一般医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・一般医薬品の市場動向・機会・課題 ・調査の結論 |
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
Market Analysis and Insights: Global Generic Drugs Market
The global Generic Drugs market was valued at US$ 313700 in 2020 and will reach US$ 555740 million by the end of 2027, growing at a CAGR of 10.0% during 2022-2027.
Global Generic Drugs Scope and Market Size
The global Generic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Generic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Simple Generic Drugs
Super Generic Drugs
Biosimilars
Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
The Generic Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Generic Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Teva
Novartis – Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy’s
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
1 Generic Drugs Market Overview
1.1 Generic Drugs Product Scope
1.2 Generic Drugs Segment by Type
1.2.1 Global Generic Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Simple Generic Drugs
1.2.3 Super Generic Drugs
1.2.4 Biosimilars
1.3 Generic Drugs Segment by Application
1.3.1 Global Generic Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Generic Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Generic Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Generic Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Generic Drugs Price Trends (2016-2027)
2 Generic Drugs Estimates and Forecasts by Region
2.1 Global Generic Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Generic Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Generic Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Generic Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Generic Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Generic Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Generic Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Generic Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Generic Drugs Estimates and Projections (2016-2027)
2.4.3 China Generic Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Generic Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Generic Drugs Estimates and Projections (2016-2027)
2.4.6 India Generic Drugs Estimates and Projections (2016-2027)
3 Global Generic Drugs Competition Landscape by Players
3.1 Global Top Generic Drugs Players by Sales (2016-2021)
3.2 Global Top Generic Drugs Players by Revenue (2016-2021)
3.3 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Generic Drugs as of 2020)
3.4 Global Generic Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Generic Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Generic Drugs Market Size by Type
4.1 Global Generic Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Generic Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Generic Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Generic Drugs Price by Type (2016-2021)
4.2 Global Generic Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Generic Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Generic Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Generic Drugs Price Forecast by Type (2022-2027)
5 Global Generic Drugs Market Size by Application
5.1 Global Generic Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Generic Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Generic Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Generic Drugs Price by Application (2016-2021)
5.2 Global Generic Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Generic Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Generic Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Generic Drugs Price Forecast by Application (2022-2027)
6 North America Generic Drugs Market Facts & Figures
6.1 North America Generic Drugs Sales by Company
6.1.1 North America Generic Drugs Sales by Company (2016-2021)
6.1.2 North America Generic Drugs Revenue by Company (2016-2021)
6.2 North America Generic Drugs Sales Breakdown by Type
6.2.1 North America Generic Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Generic Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Generic Drugs Sales Breakdown by Application
6.3.1 North America Generic Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Generic Drugs Sales Breakdown by Application (2022-2027)
7 Europe Generic Drugs Market Facts & Figures
7.1 Europe Generic Drugs Sales by Company
7.1.1 Europe Generic Drugs Sales by Company (2016-2021)
7.1.2 Europe Generic Drugs Revenue by Company (2016-2021)
7.2 Europe Generic Drugs Sales Breakdown by Type
7.2.1 Europe Generic Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Generic Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Generic Drugs Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Generic Drugs Market Facts & Figures
8.1 China Generic Drugs Sales by Company
8.1.1 China Generic Drugs Sales by Company (2016-2021)
8.1.2 China Generic Drugs Revenue by Company (2016-2021)
8.2 China Generic Drugs Sales Breakdown by Type
8.2.1 China Generic Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Generic Drugs Sales Breakdown by Type (2022-2027)
8.3 China Generic Drugs Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Generic Drugs Market Facts & Figures
9.1 Japan Generic Drugs Sales by Company
9.1.1 Japan Generic Drugs Sales by Company (2016-2021)
9.1.2 Japan Generic Drugs Revenue by Company (2016-2021)
9.2 Japan Generic Drugs Sales Breakdown by Type
9.2.1 Japan Generic Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Generic Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Generic Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Generic Drugs Market Facts & Figures
10.1 Southeast Asia Generic Drugs Sales by Company
10.1.1 Southeast Asia Generic Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Generic Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Generic Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Generic Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Generic Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Generic Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Generic Drugs Market Facts & Figures
11.1 India Generic Drugs Sales by Company
11.1.1 India Generic Drugs Sales by Company (2016-2021)
11.1.2 India Generic Drugs Revenue by Company (2016-2021)
11.2 India Generic Drugs Sales Breakdown by Type
11.2.1 India Generic Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Generic Drugs Sales Breakdown by Type (2022-2027)
11.3 India Generic Drugs Sales Breakdown by Application
11.3.1 India Generic Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Generic Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Generic Drugs Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Generic Drugs Products Offered
12.1.5 Teva Recent Development
12.2 Novartis – Sandoz
12.2.1 Novartis – Sandoz Corporation Information
12.2.2 Novartis – Sandoz Business Overview
12.2.3 Novartis – Sandoz Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis – Sandoz Generic Drugs Products Offered
12.2.5 Novartis – Sandoz Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Business Overview
12.3.3 Mylan Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Generic Drugs Products Offered
12.3.5 Mylan Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Corporation Information
12.4.2 Sun Pharmaceutical Business Overview
12.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sun Pharmaceutical Generic Drugs Products Offered
12.4.5 Sun Pharmaceutical Recent Development
12.5 Aspen
12.5.1 Aspen Corporation Information
12.5.2 Aspen Business Overview
12.5.3 Aspen Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aspen Generic Drugs Products Offered
12.5.5 Aspen Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Corporation Information
12.6.2 Fresenius Kabi Business Overview
12.6.3 Fresenius Kabi Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fresenius Kabi Generic Drugs Products Offered
12.6.5 Fresenius Kabi Recent Development
12.7 Pfizer (Hospira)
12.7.1 Pfizer (Hospira) Corporation Information
12.7.2 Pfizer (Hospira) Business Overview
12.7.3 Pfizer (Hospira) Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer (Hospira) Generic Drugs Products Offered
12.7.5 Pfizer (Hospira) Recent Development
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Business Overview
12.8.3 Sanofi Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sanofi Generic Drugs Products Offered
12.8.5 Sanofi Recent Development
12.9 Aurobindo
12.9.1 Aurobindo Corporation Information
12.9.2 Aurobindo Business Overview
12.9.3 Aurobindo Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Aurobindo Generic Drugs Products Offered
12.9.5 Aurobindo Recent Development
12.10 Lupin
12.10.1 Lupin Corporation Information
12.10.2 Lupin Business Overview
12.10.3 Lupin Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Lupin Generic Drugs Products Offered
12.10.5 Lupin Recent Development
12.11 Dr. Reddy’s
12.11.1 Dr. Reddy’s Corporation Information
12.11.2 Dr. Reddy’s Business Overview
12.11.3 Dr. Reddy’s Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Dr. Reddy’s Generic Drugs Products Offered
12.11.5 Dr. Reddy’s Recent Development
12.12 Apotex
12.12.1 Apotex Corporation Information
12.12.2 Apotex Business Overview
12.12.3 Apotex Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Apotex Generic Drugs Products Offered
12.12.5 Apotex Recent Development
12.13 Cipla
12.13.1 Cipla Corporation Information
12.13.2 Cipla Business Overview
12.13.3 Cipla Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Cipla Generic Drugs Products Offered
12.13.5 Cipla Recent Development
12.14 ENDO (Par Pharmaceutical)
12.14.1 ENDO (Par Pharmaceutical) Corporation Information
12.14.2 ENDO (Par Pharmaceutical) Business Overview
12.14.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 ENDO (Par Pharmaceutical) Generic Drugs Products Offered
12.14.5 ENDO (Par Pharmaceutical) Recent Development
12.15 Stada Arzneimittel
12.15.1 Stada Arzneimittel Corporation Information
12.15.2 Stada Arzneimittel Business Overview
12.15.3 Stada Arzneimittel Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Stada Arzneimittel Generic Drugs Products Offered
12.15.5 Stada Arzneimittel Recent Development
12.16 Krka Group
12.16.1 Krka Group Corporation Information
12.16.2 Krka Group Business Overview
12.16.3 Krka Group Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Krka Group Generic Drugs Products Offered
12.16.5 Krka Group Recent Development
12.17 Nichi-Iko Pharmaceutical
12.17.1 Nichi-Iko Pharmaceutical Corporation Information
12.17.2 Nichi-Iko Pharmaceutical Business Overview
12.17.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Nichi-Iko Pharmaceutical Generic Drugs Products Offered
12.17.5 Nichi-Iko Pharmaceutical Recent Development
12.18 Valeant
12.18.1 Valeant Corporation Information
12.18.2 Valeant Business Overview
12.18.3 Valeant Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Valeant Generic Drugs Products Offered
12.18.5 Valeant Recent Development
12.19 Zydus Cadila
12.19.1 Zydus Cadila Corporation Information
12.19.2 Zydus Cadila Business Overview
12.19.3 Zydus Cadila Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Zydus Cadila Generic Drugs Products Offered
12.19.5 Zydus Cadila Recent Development
12.20 Hikma
12.20.1 Hikma Corporation Information
12.20.2 Hikma Business Overview
12.20.3 Hikma Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Hikma Generic Drugs Products Offered
12.20.5 Hikma Recent Development
13 Generic Drugs Manufacturing Cost Analysis
13.1 Generic Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Generic Drugs
13.4 Generic Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Generic Drugs Distributors List
14.3 Generic Drugs Customers
15 Market Dynamics
15.1 Generic Drugs Market Trends
15.2 Generic Drugs Drivers
15.3 Generic Drugs Market Challenges
15.4 Generic Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Generic Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Generic Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Generic Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Generic Drugs Sales (K MT) by Region (2016-2021)
Table 5. Global Generic Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Generic Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Generic Drugs Revenue Share by Region (2016-2021)
Table 8. Global Generic Drugs Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Generic Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Generic Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Generic Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Generic Drugs Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Generic Drugs Sales Share by Company (2016-2021)
Table 14. Global Generic Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Generic Drugs Revenue Share by Company (2016-2021)
Table 16. Global Generic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Drugs as of 2020)
Table 17. Global Generic Drugs Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Generic Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Generic Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Generic Drugs Sales (K MT) by Type (2016-2021)
Table 22. Global Generic Drugs Sales Share by Type (2016-2021)
Table 23. Global Generic Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Generic Drugs Price (USD/MT) by Type (2016-2021)
Table 25. Global Generic Drugs Sales Share by Type (2022-2027)
Table 26. Global Generic Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Generic Drugs Revenue Share by Type (2022-2027)
Table 28. Global Generic Drugs Price (USD/MT) by Type (2022-2027)
Table 29. Global Generic Drugs Sales (K MT) by Application (2016-2021)
Table 30. Global Generic Drugs Sales Share by Application (2016-2021)
Table 31. Global Generic Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Generic Drugs Price (USD/MT) by Application (2016-2021)
Table 33. Global Generic Drugs Sales (K MT) by Application (2022-2027)
Table 34. Global Generic Drugs Sales Share by Application (2022-2027)
Table 35. Global Generic Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Generic Drugs Revenue Share by Application (2022-2027)
Table 37. Global Generic Drugs Price (USD/MT) by Application (2022-2027)
Table 38. North America Generic Drugs Sales (K MT) by Company (2016-2021)
Table 39. North America Generic Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Generic Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 43. North America Generic Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Generic Drugs Sales by Type (2022-2027) & (K MT)
Table 45. North America Generic Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 47. North America Generic Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Generic Drugs Sales by Application (2022-2027) & (K MT)
Table 49. North America Generic Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Generic Drugs Sales (K MT) by Company (2016-2021)
Table 51. Europe Generic Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Generic Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 55. Europe Generic Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Generic Drugs Sales by Type (2022-2027) & (K MT)
Table 57. Europe Generic Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 59. Europe Generic Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Generic Drugs Sales by Application (2022-2027) & (K MT)
Table 61. Europe Generic Drugs Sales Market Share by Application (2022-2027)
Table 62. China Generic Drugs Sales (K MT) by Company (2016-2021)
Table 63. China Generic Drugs Sales Market Share by Company (2016-2021)
Table 64. China Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Generic Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 67. China Generic Drugs Sales Market Share by Type (2016-2021)
Table 68. China Generic Drugs Sales by Type (2022-2027) & (K MT)
Table 69. China Generic Drugs Sales Market Share by Type (2022-2027)
Table 70. China Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 71. China Generic Drugs Sales Market Share by Application (2016-2021)
Table 72. China Generic Drugs Sales by Application (2022-2027) & (K MT)
Table 73. China Generic Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Generic Drugs Sales (K MT) by Company (2016-2021)
Table 75. Japan Generic Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Generic Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 79. Japan Generic Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Generic Drugs Sales by Type (2022-2027) & (K MT)
Table 81. Japan Generic Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 83. Japan Generic Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Generic Drugs Sales by Application (2022-2027) & (K MT)
Table 85. Japan Generic Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Generic Drugs Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Generic Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Generic Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Generic Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Generic Drugs Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Generic Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Generic Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Generic Drugs Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Generic Drugs Sales Market Share by Application (2022-2027)
Table 98. India Generic Drugs Sales (K MT) by Company (2016-2021)
Table 99. India Generic Drugs Sales Market Share by Company (2016-2021)
Table 100. India Generic Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Generic Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Generic Drugs Sales by Type (2016-2021) & (K MT)
Table 103. India Generic Drugs Sales Market Share by Type (2016-2021)
Table 104. India Generic Drugs Sales by Type (2022-2027) & (K MT)
Table 105. India Generic Drugs Sales Market Share by Type (2022-2027)
Table 106. India Generic Drugs Sales by Application (2016-2021) & (K MT)
Table 107. India Generic Drugs Sales Market Share by Application (2016-2021)
Table 108. India Generic Drugs Sales by Application (2022-2027) & (K MT)
Table 109. India Generic Drugs Sales Market Share by Application (2022-2027)
Table 110. Teva Corporation Information
Table 111. Teva Description and Business Overview
Table 112. Teva Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Teva Generic Drugs Product
Table 114. Teva Recent Development
Table 115. Novartis - Sandoz Corporation Information
Table 116. Novartis - Sandoz Description and Business Overview
Table 117. Novartis - Sandoz Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Novartis - Sandoz Generic Drugs Product
Table 119. Novartis - Sandoz Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Mylan Generic Drugs Product
Table 124. Mylan Recent Development
Table 125. Sun Pharmaceutical Corporation Information
Table 126. Sun Pharmaceutical Description and Business Overview
Table 127. Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Sun Pharmaceutical Generic Drugs Product
Table 129. Sun Pharmaceutical Recent Development
Table 130. Aspen Corporation Information
Table 131. Aspen Description and Business Overview
Table 132. Aspen Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Aspen Generic Drugs Product
Table 134. Aspen Recent Development
Table 135. Fresenius Kabi Corporation Information
Table 136. Fresenius Kabi Description and Business Overview
Table 137. Fresenius Kabi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Fresenius Kabi Generic Drugs Product
Table 139. Fresenius Kabi Recent Development
Table 140. Pfizer (Hospira) Corporation Information
Table 141. Pfizer (Hospira) Description and Business Overview
Table 142. Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Pfizer (Hospira) Generic Drugs Product
Table 144. Pfizer (Hospira) Recent Development
Table 145. Sanofi Corporation Information
Table 146. Sanofi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Sanofi Description and Business Overview
Table 148. Sanofi Generic Drugs Product
Table 149. Sanofi Recent Development
Table 150. Aurobindo Corporation Information
Table 151. Aurobindo Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Aurobindo Description and Business Overview
Table 153. Aurobindo Generic Drugs Product
Table 154. Aurobindo Recent Development
Table 155. Lupin Corporation Information
Table 156. Lupin Description and Business Overview
Table 157. Lupin Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Lupin Generic Drugs Product
Table 159. Lupin Recent Development
Table 160. Dr. Reddy's Corporation Information
Table 161. Dr. Reddy's Description and Business Overview
Table 162. Dr. Reddy's Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Dr. Reddy's Generic Drugs Product
Table 164. Dr. Reddy's Recent Development
Table 165. Apotex Corporation Information
Table 166. Apotex Description and Business Overview
Table 167. Apotex Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Apotex Generic Drugs Product
Table 169. Apotex Recent Development
Table 170. Cipla Corporation Information
Table 171. Cipla Description and Business Overview
Table 172. Cipla Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Cipla Generic Drugs Product
Table 174. Cipla Recent Development
Table 175. ENDO (Par Pharmaceutical) Corporation Information
Table 176. ENDO (Par Pharmaceutical) Description and Business Overview
Table 177. ENDO (Par Pharmaceutical) Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. ENDO (Par Pharmaceutical) Generic Drugs Product
Table 179. ENDO (Par Pharmaceutical) Recent Development
Table 180. Stada Arzneimittel Corporation Information
Table 181. Stada Arzneimittel Description and Business Overview
Table 182. Stada Arzneimittel Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Stada Arzneimittel Generic Drugs Product
Table 184. Stada Arzneimittel Recent Development
Table 185. Krka Group Corporation Information
Table 186. Krka Group Description and Business Overview
Table 187. Krka Group Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Krka Group Generic Drugs Product
Table 189. Krka Group Recent Development
Table 190. Nichi-Iko Pharmaceutical Corporation Information
Table 191. Nichi-Iko Pharmaceutical Description and Business Overview
Table 192. Nichi-Iko Pharmaceutical Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Nichi-Iko Pharmaceutical Generic Drugs Product
Table 194. Nichi-Iko Pharmaceutical Recent Development
Table 195. Valeant Corporation Information
Table 196. Valeant Description and Business Overview
Table 197. Valeant Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 198. Valeant Generic Drugs Product
Table 199. Valeant Recent Development
Table 200. Zydus Cadila Corporation Information
Table 201. Zydus Cadila Description and Business Overview
Table 202. Zydus Cadila Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 203. Zydus Cadila Generic Drugs Product
Table 204. Zydus Cadila Recent Development
Table 205. Hikma Corporation Information
Table 206. Hikma Description and Business Overview
Table 207. Hikma Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 208. Hikma Generic Drugs Product
Table 209. Hikma Recent Development
Table 210. Production Base and Market Concentration Rate of Raw Material
Table 211. Key Suppliers of Raw Materials
Table 212. Generic Drugs Distributors List
Table 213. Generic Drugs Customers List
Table 214. Generic Drugs Market Trends
Table 215. Generic Drugs Market Drivers
Table 216. Generic Drugs Market Challenges
Table 217. Generic Drugs Market Restraints
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
List of Figures
Figure 1. Generic Drugs Product Picture
Figure 2. Global Generic Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Generic Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. CNS Examples
Figure 7. Cardiovascular Examples
Figure 8. Genitourinary/Hormonal Drugs Examples
Figure 9. Respiratory Examples
Figure 10. Rheumatology Examples
Figure 11. Diabetes Examples
Figure 12. Oncology Examples
Figure 13. Others Examples
Figure 14. Global Generic Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Generic Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Generic Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 17. Global Generic Drugs Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 18. Global Generic Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Generic Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Generic Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 22. Europe Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Generic Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Generic Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Generic Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Generic Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Generic Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Generic Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Generic Drugs Players Market Share by Revenue in Generic Drugs: 2016 & 2020
Figure 33. Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Generic Drugs Revenue Share by Type (2016-2021)
Figure 35. Global Generic Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Generic Drugs Revenue Share by Application (2016-2021)
Figure 37. Global Generic Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Generic Drugs Sales Market Share by Type in 2020
Figure 39. North America Generic Drugs Sales Market Share by Application in 2020
Figure 40. Europe Generic Drugs Sales Market Share by Type in 2020
Figure 41. Europe Generic Drugs Sales Market Share by Application in 2020
Figure 42. China Generic Drugs Sales Market Share by Type in 2020
Figure 43. China Generic Drugs Sales Market Share by Application in 2020
Figure 44. Japan Generic Drugs Sales Market Share by Type in 2020
Figure 45. Japan Generic Drugs Sales Market Share by Application in 2020
Figure 46. Southeast Asia Generic Drugs Sales Market Share by Type in 2020
Figure 47. Southeast Asia Generic Drugs Sales Market Share by Application in 2020
Figure 48. India Generic Drugs Sales Market Share by Type in 2020
Figure 49. India Generic Drugs Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Generic Drugs
Figure 52. Manufacturing Process Analysis of Generic Drugs
Figure 53. Generic Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
世界のジェネリック腫瘍薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Generic Oncology Drugs Market The global Generic Oncology Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…- 吸入＆点鼻薬ジェネリック医薬品のグローバル市場2021 Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies. Market competition is intense among the top 4. The sales of generic inhalers and nasal sprays is expected to increase even further after th…
- 一般作物防疫のグローバル市場2021 Generic plant protection product are products that are manufactured after the expiration of a patent or other exclusive rights, by a company that did not hold the original patent, and without (the need for) a license from the original patent holder. Generic products are developed, authorised, manufa…
- 動物用ジェネリック医薬品のグローバル市場調査 2019年 The global Animal Generic Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Animal Generic Drug volume and value at global level, regional level and company level. From a global perspective, this…
- 世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…